TGA Approval

GANVADO denosumab (rch) 70mg/mL (120mg/1.7mL) solution for injection vial (461905)

ARTG ID

461905

ARTG Name

GANVADO denosumab (rch) 70mg/mL (120mg/1.7mL) solution for injection vial

Sponsor

Amgen Australia Pty Ltd

ARTG Date

November 5, 2024

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Amgen Australia Pty Ltd.

Ingredient Name

Denosumab

Empowering clinical research with data-driven insights and AI-powered tools.